ERBB2 and breast cancer: BC can be classified based on genetic/hormone characteristics, as the estrogen receptor, progesterone receptor, and the human epidermal growth factor 2 receptor (HER2) expression, being the absence of all mentioned the most aggressive phenotype, known as triple negative BC [2].